Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 ...

Natco Pharma on Tuesday said its consolidated net profit jumped 83 per cent on-year to Rs 676 crore in the September 2024 ...

Natco Pharma on November 12 said its consolidated net profit jumped 83 percent on-year to Rs 676 crore in the September 2024 ...

Natco Pharma has announced an 83 percent on-year increase in its consolidated net profit for the September 2024 quarter, ...

Dividend: Second interim dividend of INR1.5 per equity share for FY24-25. Natco Pharma Ltd (BOM:524816) reported a 35.3% increase in consolidated total revenue for Q2 FY25 compared to the same period ...

Natco Pharma reports 83% increase in net profit, 35% growth in revenue, declares second interim dividend for FY2024-25.

Natco Pharma’s board declared a second interim dividend of ₹1.50 per equity share, with a face value of ₹2, for FY 2024-25.

Natco Pharma Q2 Results Live : Natco Pharma announced its Q2 results on November 12, 2024, revealing a significant growth in ...

Natco Pharma rose 1.00% to Rs 1,409.70 after the company's consolidated net profit surged 83.55% to Rs 677.30 crore in Q2 FY25 as against Rs 369 crore reported in Q2 FY24.

Natco Pharma's net profit soared 83% YoY to Rs 676 crore in Q2 FY25, driven by strong sales growth. Revenue also increased significantly, with exports and domestic businesses performing well. New ...

Indian pharma opts for ELNs to streamline research, improve compliance and accelerate innovation: Nandita Vijayasimha, Bengaluru Friday, November 15, 2024, 08:00 Hrs [IST] Indian ...

NEW DELHI: The Nifty Pharma index traded negative around 10:53AM(IST)on Wednesday in a weak market. Natco Pharma Ltd.(up 2.46 ...